GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE1080.050.5 (+0.05 %)
PREV CLOSE ( ) 1079.55
OPEN PRICE ( ) 1081.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 13240
TODAY'S LOW / HIGH ( )1061.15 1088.35
52 WK LOW / HIGH ( )520.1 1095.95
NSE1079.35-0.95 (-0.09 %)
PREV CLOSE( ) 1080.30
OPEN PRICE ( ) 1085.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1079.35 (7)
VOLUME 475440
TODAY'S LOW / HIGH( ) 1061.25 1088.75
52 WK LOW / HIGH ( )520.1 1096
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.